» Articles » PMID: 23397510

Prolactin and Sex Steroids Levels in Congenital Lifetime Isolated GH Deficiency

Overview
Journal Endocrine
Specialty Endocrinology
Date 2013 Feb 12
PMID 23397510
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Growth hormone (GH) and prolactin share similarities in structure and function. We have previously shown that women with congenital isolated GH deficiency (IGHD) caused by a homozygous mutation in the GHRH receptor gene (GHRHR) (MUT/MUT) have a short reproductive life, with anticipated climacteric. At climacteric, they have lower prolactin levels than normal controls (N/N). Because they are able to breast feed, we hypothesized that this prolactin reduction is limited to climacteric, as result of lower estradiol exposure of the lactotrophs. The purposes of this work were to assess prolactin levels in broader age adults homozygous and heterozygous (MUT/N) for the mutation and in normal controls (N/N), and to correlate them to sex steroids levels. We enrolled 24 GH-naïve MUT/MUT (12 female), 25 MUT/N (14 female), and 25 N/N (11 female) subjects, aged 25-65 years. Anthropometric data and serum prolactin, estradiol, total testosterone, and sex hormone binding globulin (SHBG) were measured. Free testosterone was calculated. Prolactin levels were similar in the three groups. In males, testosterone and SHBG levels were higher in MUT/MUT in comparison to N/N. There was no difference in free testosterone among groups. In all 74 individuals, prolactin correlated inversely with age (p < 0.0001) and directly with serum estradiol (p = 0.018). Prolactin levels in subjects with IGHD due to a homozygous GHRHR mutation are similar to heterozygous and normal homozygous, but total testosterone and SHBG are higher in male MUT/MUT, with no difference in free testosterone. The reduced prolactin level is limited to climacteric period, possibly due to reduced estrogen exposure.

Citing Articles

Skin assessment in congenital untreated isolated GH deficiency.

Barros-Oliveira C, de Jesus M, Campos V, Salvatori R, Araujo A, Neto R Endocrine. 2024; 84(3):1116-1124.

PMID: 38703329 DOI: 10.1007/s12020-024-03840-1.


Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome.

Aguiar-Oliveira M, Salvatori R Rev Endocr Metab Disord. 2020; 22(1):81-89.

PMID: 32935264 DOI: 10.1007/s11154-020-09591-4.


Growth Hormone Deficiency: Health and Longevity.

Aguiar-Oliveira M, Bartke A Endocr Rev. 2018; 40(2):575-601.

PMID: 30576428 PMC: 6416709. DOI: 10.1210/er.2018-00216.


Infectious diseases and immunological responses in adult subjects with lifetime untreated, congenital GH deficiency.

Campos V, Barrios M, Salvatori R, Pacheco de Almeida R, de Melo E, Nascimento A Endocrine. 2016; 54(1):182-190.

PMID: 27484773 DOI: 10.1007/s12020-016-1061-z.


Sex Hormone-Binding Globulin in Children and Adolescents.

Aydin B, Winters S J Clin Res Pediatr Endocrinol. 2016; 8(1):1-12.

PMID: 26761949 PMC: 4805039. DOI: 10.4274/jcrpe.2764.

References
1.
Follin C, Link K, Wiebe T, Moell C, Bjork J, Erfurth E . Prolactin insufficiency but normal thyroid hormone levels after cranial radiotherapy in long-term survivors of childhood leukaemia. Clin Endocrinol (Oxf). 2012; 79(1):71-8. DOI: 10.1111/cen.12111. View

2.
Foss M, Paula F, Paccola G, Piccinato C . Peripheral glucose metabolism in human hyperprolactinaemia. Clin Endocrinol (Oxf). 1995; 43(6):721-6. DOI: 10.1111/j.1365-2265.1995.tb00541.x. View

3.
Oliveira C, Salvatori R, Barreto-Filho J, Rocha I, Mari A, Pereira R . Insulin sensitivity and β-cell function in adults with lifetime, untreated isolated growth hormone deficiency. J Clin Endocrinol Metab. 2011; 97(3):1013-9. DOI: 10.1210/jc.2011-2590. View

4.
Fleenor D, Freemark M . Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. Endocrinology. 2001; 142(7):2805-10. DOI: 10.1210/endo.142.7.8267. View

5.
Pugeat M, Nader N, Hogeveen K, Raverot G, Dechaud H, Grenot C . Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol Cell Endocrinol. 2009; 316(1):53-9. DOI: 10.1016/j.mce.2009.09.020. View